Arctech Innovation has announced the appointment of Graeme Cleland as Chief Business Officer.

Graeme will take up the position on Monday 14th March, and brings with him over 20 years of commercial leadership experience with a strong track record for business transformation, operational management and profit growth in the medical and healthcare sector.

Most recently, Graeme successfully oversaw a significant increase in profitable turnover at SYNLAB UK, an international medical diagnostics provider, with an emphasis on strategic business development and developing client relationships.

Prior to SYNLAB UK, Graeme was the Managing Director of Taurus Healthcare, a federation of 20 Herefordshire-based General Practices, joining in 2012 where he was a key driver behind several successful tenders and cost reduction programmes.

Graeme has also held senior leadership roles at Sk:n, In Health Group and Clinovia during his distinguished business management career.

As Chief Business Officer, Graeme will play a critical role in Arctech Innovation’s senior leadership team, implementing the commercial strategy, and will be a central figure driving its growth ambitions.

Graeme’s appointment comes at an exciting time for Arctech Innovation as it seeks to raise £5M in Series A investment to bring to market its innovative range of odour-based diagnostic and insect control solutions.

“Graeme is an incredibly capable leader who has been instrumental in driving commercial success and business transformation for several companies in the healthcare industry,” commented Professor James Logan, Co-founder and CEO of Arctech Innovation. “Graeme’s business management experience, expertise and proven track record of major successes will be invaluable to our senior leadership team.”

“I am thrilled to join Arctech Innovation and its forward-thinking, innovative team tackling critical public health problems,” added Graeme. “I look forward to enhancing the commercial capabilities at Arctech Innovation to achieve our goal of bringing life-saving disease detection and insect control technologies to market.”